Showing 58,881 - 58,900 results of 113,932 for search '(( 5 ((mean decrease) OR (a decrease)) ) OR ( a ((fold decrease) OR (point decrease)) ))', query time: 1.49s Refine Results
  1. 58881

    Presentation_1_Single institution experience of MRI-guided radiotherapy for thoracic tumors and clinical characteristics impacting treatment duty cycle.pptx by Joseph A. Miccio (17074060)

    Published 2024
    “…There was no plan adaptation for patients treated due to motion management (n=11). Mean GTV motion was significantly higher for patients treated due to motion management compared to OAR (16.1mm vs. 6.5mm, p=0.011). …”
  2. 58882

    Data_Sheet_1_Effect of Groundwater on Noise-Based Monitoring of Crustal Velocity Changes Near a Produced Water Injection Well in Val d'Agri (Italy).PDF by Andrea Berbellini (10507442)

    Published 2021
    “…We then remove from the relative velocity trend the contribution of hydrological variations and observe a decrease in relative velocity of ≈ 0.08% starting seven days after the injection restart. …”
  3. 58883

    Table 1_Efficacy and safety of cadonilimab combined with AG chemotherapy in patients with unresectable locally advanced or metastatic pancreatic ductal adenocarcinoma: a retrospect... by Wenke Qin (20390989)

    Published 2025
    “…</p>Results<p>The disease control rate (DCR) reached 85.7%, and the objective response rate (ORR) was 14.3%; the median progression-free survival (mPFS) was 7.87 months, and the median overall survival (mOS) was 11.45 months. Among patients with a decrease in CA19-9, the median overall survival was significantly prolonged (12.92 vs 8.89 months, P = 0.027); patients with a platelet-lymphocyte ratio (PLR) ≤ 165.62 had a significantly better mOS (12.37 vs 8.74 months, P = 0.025). …”
  4. 58884
  5. 58885

    FIGURE 6 from Genome-wide CRISPR Screen Reveals RAB10 as a Synthetic Lethal Gene in Colorectal and Pancreatic Cancers Carrying SMAD4 Loss by Hélène Erasimus (15410643)

    Published 2023
    “…<b>A,</b> RAB10 expression assessed with Western blot analysis in the HT29_C4, SW620_C4, DLD1_C5 and MIAPaCa-2_C17 clones expressing Cas9 and infected with sgRNA against RAB10 (sgRNA #13 and sgRNA #14) and control nontargeting sgRNA (sgRNA #NT). …”
  6. 58886

    Exposure of PS in eggs incubated with different activating agents. by Claudio A. Curia (443056)

    Published 2013
    “…<p>(<b>A</b>) ZP-free eggs were parthenogenetically activated with either 10 mM SrCl<sub>2</sub> (a), 7% ethanol (b) or 5 µM Ca<sup>2+</sup> ionophore A23187 (c). …”
  7. 58887

    Image_2_Clinical Utility of 18F-PSMA-1007 Positron Emission Tomography/Magnetic Resonance Imaging in Prostate Cancer: A Single-Center Experience.tif by Ao Liu (481251)

    Published 2021
    “…The highest proportion of management changes occurred in BCR patients with 0.5≤PSA<1 ng/ml.</p>Conclusion<p>From our preliminary experience, PSMA-PET/MRI may be a valued tool for defining PCa lesions and changing management. …”
  8. 58888

    Table_1_Clinical Utility of 18F-PSMA-1007 Positron Emission Tomography/Magnetic Resonance Imaging in Prostate Cancer: A Single-Center Experience.docx by Ao Liu (481251)

    Published 2021
    “…The highest proportion of management changes occurred in BCR patients with 0.5≤PSA<1 ng/ml.</p>Conclusion<p>From our preliminary experience, PSMA-PET/MRI may be a valued tool for defining PCa lesions and changing management. …”
  9. 58889

    Image_3_Clinical Utility of 18F-PSMA-1007 Positron Emission Tomography/Magnetic Resonance Imaging in Prostate Cancer: A Single-Center Experience.tiff by Ao Liu (481251)

    Published 2021
    “…The highest proportion of management changes occurred in BCR patients with 0.5≤PSA<1 ng/ml.</p>Conclusion<p>From our preliminary experience, PSMA-PET/MRI may be a valued tool for defining PCa lesions and changing management. …”
  10. 58890

    Image_1_Clinical Utility of 18F-PSMA-1007 Positron Emission Tomography/Magnetic Resonance Imaging in Prostate Cancer: A Single-Center Experience.tif by Ao Liu (481251)

    Published 2021
    “…The highest proportion of management changes occurred in BCR patients with 0.5≤PSA<1 ng/ml.</p>Conclusion<p>From our preliminary experience, PSMA-PET/MRI may be a valued tool for defining PCa lesions and changing management. …”
  11. 58891
  12. 58892
  13. 58893
  14. 58894
  15. 58895
  16. 58896
  17. 58897
  18. 58898

    S1 Data - by Taher Mohammadizad (19786989)

    Published 2024
    “…The six HS treatments included birds exposed to a cyclic HS environment (34°C) for 8 h and were as follows: HSC, which consisted of the same basal diet with the recommended ITM levels; ACTM50 and ACTM100, which replaced the basal diet with 50% and 100% ACTM instead of ITM; ITM+ACTM12.5 and ITM+ACTM25, which involved adding extra ACTM to the ITM basal diet at 12.5% and 25%, respectively; and ITM125, which used 125% of the recommended levels of ITM in the basal diet. …”
  19. 58899

    Data_Sheet_1_Deep brain stimulation for treatment resistant obsessive compulsive disorder; an observational study with ten patients under real-life conditions.docx by Mohamed A. Abdelnaim (16976001)

    Published 2023
    “…</p>Results<p>One patient has retracted his consent to publish the results of his treatment, thus we are reporting the results of 10 patients (5 males, 5 females, mean age: 37 years). Out of our 10 patients, 6 have shown a clear response indicated by a YBOCS-reduction between 42 and 100 percent at last follow-up. …”
  20. 58900